{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T01:09:09Z","timestamp":1773623349944,"version":"3.50.1"},"reference-count":137,"publisher":"Pleiades Publishing Ltd","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1134\/s0006297922080089","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T13:03:06Z","timestamp":1660568586000},"page":"762-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proteomic Markers and Early Prediction of Alzheimer\u2019s Disease"],"prefix":"10.1134","volume":"87","author":[{"given":"Natalia V.","family":"Zakharova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna E.","family":"Bugrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I.","family":"Indeykina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yana B.","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor V.","family":"Kolykhalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana I.","family":"Gavrilova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny N.","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey S.","family":"Kononikhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"2345_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","author":"Alzheimer\u2019s Association","year":"2021","unstructured":"Alzheimer\u2019s Association (2021) 2021 Alzheimer\u2019s disease facts and figures, Alzheimer\u2019s Dement., 17, 327-406, \nhttps:\/\/doi.org\/10.1002\/alz.12328.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M. Prince","year":"2013","unstructured":"Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., et al. (2013) The global prevalence of dementia: A systematic review and metaanalysis, Alzheimer\u2019s Dement., 9, 63-75, \nhttps:\/\/doi.org\/10.1016\/j.jalz.2012.11.007.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"C. R. Jack Jr.","year":"2013","unstructured":"Jack, C. R. Jr., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., et al. (2013) Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers, Lancet Neurol., 12, 207-216, \nhttps:\/\/doi.org\/10.1016\/S1474-4422(12)70291-0.","journal-title":"Lancet Neurol."},{"key":"2345_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00415-012-6694-0","volume":"260","author":"S. Galluzzi","year":"2013","unstructured":"Galluzzi, S., Geroldi, C., Amicucci, G., Bocchio-Chiavetto, L., Bonetti, M., et al. (2013) Supporting evidence for using biomarkers in the diagnosis of MCI due to AD, J. Neurol., 260, 640-650, \nhttps:\/\/doi.org\/10.1007\/s00415-012-6694-0.","journal-title":"J. Neurol."},{"key":"2345_CR5","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","volume":"461","author":"R. J. Perrin","year":"2009","unstructured":"Perrin, R. J., Fagan, A. M., and Holtzman, D. M. (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease, Nature, 461, 916-922, \nhttps:\/\/doi.org\/10.1038\/nature08538.","journal-title":"Nature"},{"key":"2345_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"J. M. Long","year":"2019","unstructured":"Long, J. M., and Holtzman, D. M. (2019) Alzheimer\u2019s disease: an update on pathobiology and treatment strategies, Cell, 179, 312-339, \nhttps:\/\/doi.org\/10.1016\/j.cell.2019.09.001.","journal-title":"Cell"},{"key":"2345_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C. Duyckaerts","year":"2009","unstructured":"Duyckaerts, C., Delatour, B., and Potier, M. C. (2009) Classification and basic pathology of Alzheimer\u2019s disease, Acta Neuropathol., 118, 5-36, \nhttps:\/\/doi.org\/10.1007\/s00401-009-0532-1.","journal-title":"Acta Neuropathol."},{"key":"2345_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"Jr. C. R. Jack","year":"2018","unstructured":"Jack, Jr. C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., et al. (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease, Alzheimer\u2019s Dement., 14, 535-562, \nhttps:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR9","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/wnl.52.7.1397","volume":"52","author":"C. R. Jack","year":"1999","unstructured":"Jack, C. R., Petersen, R. C., Xu, Y. C., O\u2019Brien, P. C., Smith, G. E., et al. (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment, Neurology, 52, 1397-1397, \nhttps:\/\/doi.org\/10.1212\/wnl.52.7.1397.","journal-title":"Neurology"},{"key":"2345_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/WNL.0b013e31823efc6c","volume":"78","author":"B. C. Dickerson","year":"2012","unstructured":"Dickerson, B. C., and Wolk, D. A. (2012) MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults, Neurology, 78, 84-90, \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e31823efc6c.","journal-title":"Neurology"},{"key":"2345_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I","volume":"47","author":"R. J. Killiany","year":"2000","unstructured":"Killiany, R. J., Gomez\u2010Isla, T., Moss, M., Kikinis, R., Sandor, T., et al. (2000) Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease, Ann. Neurol., 47, 430-439.","journal-title":"Ann. Neurol."},{"key":"2345_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","volume":"4","author":"H. Hampel","year":"2008","unstructured":"Hampel, H., B\u00fcrger, K., Teipel, S. J., Bokde, A. L., Zetterberg, H., et al. (2008) Core candidate neurochemical and imaging biomarkers of Alzheimer\u2019s disease, Alzheimer\u2019s Dement., 4, 38-48, \nhttps:\/\/doi.org\/10.1016\/j.jalz.2007.08.006.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR13","doi-asserted-by":"crossref","unstructured":"Petersen, R. C. (2003) Mild Cognitive Impairment: Aging to Alzheimer\u2019s Disease, Oxford University Press.","DOI":"10.1093\/oso\/9780195123425.001.0001"},{"key":"2345_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","volume":"6","author":"K. Blennow","year":"2017","unstructured":"Blennow, K. (2017) A review of fluid biomarkers for Alzheimer\u2019s disease: moving from CSF to blood, Neurol. Ther., 6, 15-24, \nhttps:\/\/doi.org\/10.1007\/s40120-017-0073-9.","journal-title":"Neurol. Ther."},{"key":"2345_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/156720506776383103","volume":"3","author":"P. J. Modrego","year":"2006","unstructured":"Modrego, P. J. (2006) Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment, Curr. Alzheimer Res., 3, 161-170, \nhttps:\/\/doi.org\/10.2174\/156720506776383103.","journal-title":"Curr. Alzheimer Res."},{"key":"2345_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1742-1241.2011.02845.x","volume":"66","author":"S. Zhang","year":"2012","unstructured":"Zhang, S., Han, D., Tan, X., Feng, J., Guo, Y., et al. (2012) Diagnostic accuracy of 18 F-FDG and 11 C-PIB\u2013PET for prediction of short-term conversion to Alzheimer\u2019s disease in subjects with mild cognitive impairment, Int. J. Clin. Pract., 66, 185-198, \nhttps:\/\/doi.org\/10.1111\/j.1742-1241.2011.02845.x.","journal-title":"Int. J. Clin. Pract."},{"key":"2345_CR17","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","volume":"68","author":"C. C. Rowe","year":"2007","unstructured":"Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., et al. (2007) Imaging \u03b2-amyloid burden in aging and dementia, Neurology, 68, 1718-1725, \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000261919.22630.ea.","journal-title":"Neurology"},{"key":"2345_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejrad.2017.07.014","volume":"94","author":"L. Rice","year":"2017","unstructured":"Rice, L., and Bisdas, S. (2017) The diagnostic value of FDG and amyloid PET in Alzheimer\u2019s disease \u2013 A systematic review, Eur. J. Radiol., 94, 16-24, \nhttps:\/\/doi.org\/10.1016\/j.ejrad.2017.07.014.","journal-title":"Eur. J. Radiol."},{"key":"2345_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"H. Hampel","year":"2018","unstructured":"Hampel, H., O\u2019Bryant, S. E., Molinuevo, J. L., Zetterberg, H., Masters, C., et al. (2018) Blood-based biomarkers for Alzheimer\u2019s disease: mapping the road to the clinic, Nat. Rev. Neurol., 14, 639-652, \nhttps:\/\/doi.org\/10.1038\/s41582-018-0079-7.","journal-title":"Nat. Rev. Neurol."},{"key":"2345_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/prca.200780040","volume":"2","author":"S. Roche","year":"2008","unstructured":"Roche, S., Gabelle, A., and Lehmann, S. (2008) Clinical proteomics of the cerebrospinal fluid: towards the discovery of new biomarkers, Proteomics Clin. Appl., 2, 428-436, \nhttps:\/\/doi.org\/10.1002\/prca.200780040.","journal-title":"Proteomics Clin. Appl."},{"key":"2345_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jprot.2010.11.010","volume":"74","author":"A. C. Kroksveen","year":"2011","unstructured":"Kroksveen, A. C., Opsahl, J. A., Aye, T. T., Ulvik, R. J., and Berven, F. S. (2011) Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics, J. Proteomics, 74, 371-388, \nhttps:\/\/doi.org\/10.1016\/j.jprot.2010.11.010.","journal-title":"J. Proteomics"},{"key":"2345_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T. Tapiola","year":"2009","unstructured":"Tapiola, T., Alafuzoff, I., Herukka, S. K., Parkkinen, L., Hartikainen, P., et al. (2009) Cerebrospinal fluid \u03b2-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain, Arch. Neurol., 66, 382-389, \nhttps:\/\/doi.org\/10.1001\/archneurol.2008.596.","journal-title":"Arch. Neurol."},{"key":"2345_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010803","volume":"3","author":"C. Ritchie","year":"2013","unstructured":"Ritchie, C., Smailagic, N., Ladds, E. C., Noel-Storr, A. H., Ukoumunne, O., et al. (2013) CSF tau and the CSF tau\/ABeta ratio for the diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI), Cochrane Database Syst. Rev., 3, CD10803, \nhttps:\/\/doi.org\/10.1002\/14651858.CD010803.","journal-title":"Cochrane Database Syst. Rev."},{"key":"2345_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.biopsych.2009.01.027","volume":"65","author":"T. Grimmer","year":"2009","unstructured":"Grimmer, T., Riemenschneider, M., Fors, H., Henriksen, G., Klunk, W. E., et al. (2009) Beta amyloid in Alzheimer\u2019s disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid, Biol. Psychiatry, 65, 927-934, \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2009.01.027.","journal-title":"Biol. Psychiatry"},{"key":"2345_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnagi.2014.00047","volume":"6","author":"D. Ferreira","year":"2014","unstructured":"Ferreira, D., Perestelo-P\u00e9rez, L., Westman, E., Wahlund, L. O., Sarr\u00eda, A., et al. (2014) Meta-review of CSF core biomarkers in Alzheimer\u2019s disease: the state-of-the-art after the new revised diagnostic criteria, Front. Aging Neurosci., 6, 47, \nhttps:\/\/doi.org\/10.3389\/fnagi.2014.00047.","journal-title":"Front. Aging Neurosci."},{"key":"2345_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"G. M. McKhann","year":"2011","unstructured":"McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, Jr. C. R., et al. (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease, Alzheimer\u2019s Dement., 7, 263-269, \nhttps:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR27","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/brain\/awv055","volume":"138","author":"J. M. Schott","year":"2015","unstructured":"Schott, J. M., and Petersen, R. C. (2015) New criteria for Alzheimer\u2019s disease: which, when and why? Brain, 138, 1134-1137, \nhttps:\/\/doi.org\/10.1093\/brain\/awv055.","journal-title":"Brain"},{"key":"2345_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B. Olsson","year":"2016","unstructured":"Olsson, B., Lautner, R., Andreasson, U., \u00d6hrfelt, A., Portelius, E., et al. (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis, Lancet Neurol., 15, 673-684, \nhttps:\/\/doi.org\/10.1016\/S1474-4422(16)00070-3.","journal-title":"Lancet Neurol."},{"key":"2345_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-8-20","volume":"8","author":"C. Ros\u00e9n","year":"2013","unstructured":"Ros\u00e9n, C., Hansson, O., Blennow, K., and Zetterberg, H. (2013) Fluid biomarkers in Alzheimer\u2019s disease \u2013 current concepts, Mol. Neurodegener., 8, 20, \nhttps:\/\/doi.org\/10.1186\/1750-1326-8-20.","journal-title":"Mol. Neurodegener."},{"key":"2345_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fneur.2017.00102","volume":"8","author":"R. A. Huynh","year":"2017","unstructured":"Huynh, R. A., and Mohan, C. (2017) Alzheimer\u2019s disease: biomarkers in the genome, blood, and cerebrospinal fluid, Front. Neurol., 8, 102, \nhttps:\/\/doi.org\/10.3389\/fneur.2017.00102.","journal-title":"Front. Neurol."},{"key":"2345_CR31","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","volume":"13","author":"V. Ovod","year":"2017","unstructured":"Ovod, V., Ramsey, K. N., Mawuenyega, K. G., Bollinger, J. G., Hicks, T., et al. (2017) Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis, Alzheimer\u2019s Dement., 13, 841-849, \nhttps:\/\/doi.org\/10.1016\/j.jalz.2017.06.2266.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A. Nakamura","year":"2018","unstructured":"Nakamura, A., Kaneko, N., Villemagne, V. L., Kato, T., Doecke, J., et al. (2018) High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease, Nature, 554, 249-254, \nhttps:\/\/doi.org\/10.1038\/nature25456.","journal-title":"Nature"},{"key":"2345_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-021-00430-x","volume":"16","author":"H. Zetterberg","year":"2021","unstructured":"Zetterberg, H., and Blennow, K. (2021) Moving fluid biomarkers for Alzheimer\u2019s disease from research tools to routine clinical diagnostics, Mol. Neurodegener., 16, 10, \nhttps:\/\/doi.org\/10.1186\/s13024-021-00430-x.","journal-title":"Mol. Neurodegener."},{"key":"2345_CR34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200861","volume":"217","author":"N. R. Barthelemy","year":"2020","unstructured":"Barthelemy, N. R., Horie, K., Sato, C., and Bateman, R. J. (2020) Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease, J. Exp. Med., 217, e20200861, \nhttps:\/\/doi.org\/10.1084\/jem.20200861.","journal-title":"J. Exp. Med."},{"key":"2345_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/mas.21775","author":"N. V. Zakharova","year":"2022","unstructured":"Zakharova, N. V., Kononikhin, A. S., Indeykina, M. I., Bugrova, A. E., Strelnikova, P., et al. (2022) Mass spectrometric studies of the variety of beta-amyloid proteofprms in Alzheimer\u2019s disease, Mass Spectrom. Rev., e21775, \nhttps:\/\/doi.org\/10.1002\/mas.21775.","journal-title":"Mass Spectrom. Rev."},{"key":"2345_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jnr.10745","volume":"74","author":"G. Evin","year":"2003","unstructured":"Evin, G., Zhu, A., Holsinger, R. M. D., Masters, C. L., and Li, Q. X. (2003) Proteolytic processing of the Alzheimer\u2019s disease amyloid precursor protein in brain and platelets, J. Neurosci. Res., 74, 386-392, \nhttps:\/\/doi.org\/10.1002\/jnr.10745.","journal-title":"J. Neurosci. Res."},{"key":"2345_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1586\/14789450.2015.1065183","volume":"12","author":"S. Galozzi","year":"2015","unstructured":"Galozzi, S., Marcus, K., and Barkovits, K. (2015) Amyloid-\u03b2 as a biomarker for Alzheimer\u2019s disease: quantification methods in body fluids, Expert. Rev. Proteomics, 12, 343-354, \nhttps:\/\/doi.org\/10.1586\/14789450.2015.1065183.","journal-title":"Expert. Rev. Proteomics"},{"key":"2345_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.sbi.2019.09.001","volume":"60","author":"R. Gallardo","year":"2020","unstructured":"Gallardo, R., Ranson, N. A., and Radford, S. E. (2020) Amyloid structures: much more than just a cross-\u03b2 fold, Curr. Opin. Struct. Biol., 60, 7-16, \nhttps:\/\/doi.org\/10.1016\/j.sbi.2019.09.001.","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2345_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"S. A. Kent","year":"2020","unstructured":"Kent, S. A., Spires-Jones, T. L., and Durrant, C. S. (2020) The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics, Acta Neuropathol., 140, 417-447, \nhttps:\/\/doi.org\/10.1007\/s00401-020-02196-w.","journal-title":"Acta Neuropathol."},{"key":"2345_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/glia.10153","volume":"40","author":"J. Rogers","year":"2002","unstructured":"Rogers, J., Strohmeyer, R., Kovelowski, C. J., and Li, R. (2002) Microglia and inflammatory mechanisms in the clearance of amyloid \u03b2 peptide, Glia, 40, 260-269, \nhttps:\/\/doi.org\/10.1002\/glia.10153.","journal-title":"Glia"},{"key":"2345_CR41","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J. Wang","year":"2017","unstructured":"Wang, J., Gu, B. J., Masters, C. L., and Wang, Y. J. (2017) A systemic view of Alzheimer disease \u2013 Insights from amyloid-\u03b2 metabolism beyond the brain, Nat. Rev. Neurol., 13, 612-623, \nhttps:\/\/doi.org\/10.1038\/nrneurol.2017.111.","journal-title":"Nat. Rev. Neurol."},{"key":"2345_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/alzrt258","volume":"6","author":"M. P. Kummer","year":"2014","unstructured":"Kummer, M. P., and Heneka, M. T. (2014) Truncated and modified amyloid-beta species, Alzheimer\u2019s Res. Ther., 6, 28, \nhttps:\/\/doi.org\/10.1186\/alzrt258.","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"2345_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2017.08.007","volume":"110","author":"A. E. Roher","year":"2017","unstructured":"Roher, A. E., Kokjohn, T. A., Clarke, S. G., Sierks, M. R., Maarouf, C. L., et al. (2017) APP\/A\u03b2 structural diversity and Alzheimer\u2019s disease pathogenesis, Neurochem. Int., 110, 1-13, \nhttps:\/\/doi.org\/10.1016\/j.neuint.2017.08.007.","journal-title":"Neurochem. Int."},{"key":"2345_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0485-0","volume":"11","author":"O. Hansson","year":"2019","unstructured":"Hansson, O., Lehmann, S., Otto, M., Zetterberg, H., and Lewczuk, P. (2019) Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s disease, Alzheimers Res. Ther., 11, 1-15, \nhttps:\/\/doi.org\/10.1186\/s13195-019-0485-0.","journal-title":"Alzheimers Res. Ther."},{"key":"2345_CR45","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ana.24270","volume":"76","author":"K. F. Roberts","year":"2014","unstructured":"Roberts, K. F., Elbert, D. L., Kasten, T. P., Patterson, B. W., Sigurdson, W. C., et al. (2014) Amyloid\u2010\u03b2 efflux from the central nervous system into the plasma, Ann. Neurol., 76, 837-844, \nhttps:\/\/doi.org\/10.1002\/ana.24270.","journal-title":"Ann. Neurol."},{"key":"2345_CR46","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jlb.66.4.567","volume":"66","author":"Q. X. Li","year":"1999","unstructured":"Li, Q. X., Fuller, S. J., Beyreuther, K., and Masters, C. L. (1999) The amyloid precursor protein of Alzheimer disease in human brain and blood, J. Leukoc. Biol., 66, 567-574, \nhttps:\/\/doi.org\/10.1002\/jlb.66.4.567.","journal-title":"J. Leukoc. Biol."},{"key":"2345_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.exger.2009.08.004","volume":"45","author":"B. Borroni","year":"2010","unstructured":"Borroni, B., Agosti, C., Marcello, E., Di Luca, M., and Padovani, A. (2010) Blood cell markers in Alzheimer disease: amyloid precursor protein form ratio in platelets, Exp. Gerontol., 45, 53-56, \nhttps:\/\/doi.org\/10.1016\/j.exger.2009.08.004.","journal-title":"Exp. Gerontol."},{"key":"2345_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0014-2999(00)00559-8","volume":"405","author":"M. Di Luca","year":"2000","unstructured":"Di Luca, M., Colciaghi, F., Pastorino, L., Borroni, B., Padovani, A., et al. (2000) Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein, Eur. J. Pharmacol., 405, 277-283, \nhttps:\/\/doi.org\/10.1016\/s0014-2999(00)00559-8.","journal-title":"Eur. J. Pharmacol."},{"key":"2345_CR49","doi-asserted-by":"publisher","first-page":"18135","DOI":"10.1073\/pnas.0507798102","volume":"102","author":"F. Xu","year":"2005","unstructured":"Xu, F., Davis, J., Miao, J., Previti, M. L., Romanov, G., et al. (2005) Protease nexin-2\/amyloid \u03b2-protein precursor limits cerebral thrombosis, Proc. Natl. Acad. Sci. USA, 102, 18135-18140, \nhttps:\/\/doi.org\/10.1073\/pnas.0507798102.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2345_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jbiotec.2021.02.016","volume":"330","author":"L. J. Eltringham-Smith","year":"2021","unstructured":"Eltringham-Smith, L. J., Bhakta, V., and Sheffield, W. P. (2021) Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin, J. Biotechnol., 330, 61-69, \nhttps:\/\/doi.org\/10.1016\/j.jbiotec.2021.02.016.","journal-title":"J. Biotechnol."},{"key":"2345_CR51","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/01.wnl.0000106953.49802.9c","volume":"62","author":"F. Colciaghi","year":"2004","unstructured":"Colciaghi, F., Marcello, E., Borroni, B., Zimmermann, M., Caltagirone, C., et al. (2004) Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer\u2019s disease, Neurology, 62, 498-501, \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000106953.49802.9c.","journal-title":"Neurology"},{"key":"2345_CR52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/bbrc.1995.2103","volume":"213","author":"M. Chen","year":"1995","unstructured":"Chen, M., Inestrosa, N. C., Ross, G. S., and Fernandez, H. L. (1995) Platelets are the primary source of amyloid \u03b2-peptide in human blood, Biochem. Biophys. Res. Commun., 213, 96-103, \nhttps:\/\/doi.org\/10.1006\/bbrc.1995.2103.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2345_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3948360","volume":"2017","author":"M. Y. Inyushin","year":"2017","unstructured":"Inyushin, M. Y., Sanabria, P., Rojas, L., Kucheryavykh, Y., and Kucheryavykh, L. (2017) A\u03b2 peptide originated from platelets promises new strategy in anti-Alzheimer\u2019s drug development, Biomed. Res. Int., 2017, 3948360, \nhttps:\/\/doi.org\/10.1155\/2017\/3948360.","journal-title":"Biomed. Res. Int."},{"key":"2345_CR54","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1196\/annals.1397.082","volume":"1096","author":"T. Casoli","year":"2007","unstructured":"Casoli, T., Di Stefano, G., Giorgetti, B., Grossi, Y., Balietti, M., et al. (2007) Release of \u03b2-amyloid from high\u2010density platelets: implications for Alzheimer\u2019s disease pathology, Ann. N Y Acad. Sci., 1096, 170-178, \nhttps:\/\/doi.org\/10.1196\/annals.1397.082.","journal-title":"Ann. N Y Acad. Sci."},{"key":"2345_CR55","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"S. E. Schindler","year":"2019","unstructured":"Schindler, S. E., Bollinger, J. G., Ovod, V., Mawuenyega, K. G., Li, Y., et al. (2019) High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis, Neurology, 93, e1647-e1659, \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000008081.","journal-title":"Neurology"},{"key":"2345_CR56","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1021\/pr0703627","volume":"6","author":"E. Portelius","year":"2007","unstructured":"Portelius, E., Tran, A. J., Andreasson, U., Persson, R., Brinkmalm, G., et al. (2007) Characterization of amyloid \u03b2 peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry, J. Proteome Res., 6, 4433-4439, \nhttps:\/\/doi.org\/10.1021\/pr0703627.","journal-title":"J. Proteome Res."},{"key":"2345_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1567205014666170417111859","volume":"15","author":"Y. Gao","year":"2018","unstructured":"Gao, Y., Tan, L., Yu, J. T., and Tan, L. (2018) Tau in Alzheimer\u2019s disease: Mechanisms and therapeutic strategies, Curr. Alzheimer Res., 15, 283-300, \nhttps:\/\/doi.org\/10.2174\/1567205014666170417111859.","journal-title":"Curr. Alzheimer Res."},{"key":"2345_CR58","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00702-004-0221-0","volume":"112","author":"C. X. Gong","year":"2005","unstructured":"Gong, C. X., Liu, F., Grundke-Iqbal, I., and Iqbal, K. (2005) Post-translational modifications of tau protein in Alzheimer\u2019s disease, J. Neural Transm., 112, 813-838, \nhttps:\/\/doi.org\/10.1007\/s00702-004-0221-0.","journal-title":"J. Neural Transm."},{"key":"2345_CR59","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","volume":"7","author":"K. Iqbal","year":"2010","unstructured":"Iqbal, K., Liu, F., Gong, C. X., and Grundke-Iqbal, I. (2010) Tau in Alzheimer disease and related tauopathies, Curr. Alzheimer Res., 7, 656-664, \nhttps:\/\/doi.org\/10.2174\/156720510793611592.","journal-title":"Curr. Alzheimer Res."},{"key":"2345_CR60","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.neurobiolaging.2011.02.022","volume":"33","author":"L. C. De Souza","year":"2012","unstructured":"De Souza, L. C., Chupin, M., Lamari, F., Jardel, C., Leclercq, D., et al. (2012) CSF tau markers are correlated with hippocampal volume in Alzheimer\u2019s disease, Neurobiol. Aging, 33, 1253-1257, \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.02.022.","journal-title":"Neurobiol. Aging"},{"key":"2345_CR61","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182563bd0","volume":"78","author":"T. T. Sepp\u00e4l\u00e4","year":"2012","unstructured":"Sepp\u00e4l\u00e4, T. T., Nerg, O., Koivisto, A. M., Rummukainen, J., Puli, L., et al. (2012) CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings, Neurology, 78, 1568-1575, \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e3182563bd0.","journal-title":"Neurology"},{"key":"2345_CR62","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","volume":"26","author":"N. R. Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy, N. R., Li, Y., Joseph-Mathurin, N., Gordon, B. A., Hassenstab, J., et al. (2020) A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer\u2019s disease, Nat. Med., 26, 398-407, \nhttps:\/\/doi.org\/10.1038\/s41591-020-0781-z.","journal-title":"Nat. Med."},{"key":"2345_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15436-0","volume":"11","author":"S. Janelidze","year":"2020","unstructured":"Janelidze, S., Stomrud, E., Smith, R., Palmqvist, S., Mattsson, N., et al. (2020) Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease, Nat. Commun., 11, 1-12, \nhttps:\/\/doi.org\/10.1038\/s41467-020-15436-0.","journal-title":"Nat. Commun."},{"key":"2345_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt163","volume":"5","author":"H. Zetterberg","year":"2013","unstructured":"Zetterberg, H., Wilson, D., Andreasson, U., Minthon, L., Blennow, K., et al. (2013) Plasma tau levels in Alzheimer\u2019s disease, Alzheimers Res. Ther., 5, 1-3, \nhttps:\/\/doi.org\/10.1186\/alzrt163.","journal-title":"Alzheimers Res. Ther."},{"key":"2345_CR65","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1093\/clinchem\/47.10.1776","volume":"47","author":"M. Sjogren","year":"2001","unstructured":"Sjogren, M., Vanderstichele, H., \u00c5gren, H., Zachrisson, O., Edsbagge, M., et al. (2001) Tau and A\u03b242 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values, Clin. Chem., 47, 1776-1781, \nhttps:\/\/doi.org\/10.1093\/clinchem\/47.10.1776.","journal-title":"Clin. Chem."},{"key":"2345_CR66","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"M. M. Mielke","year":"2018","unstructured":"Mielke, M. M., Hagen, C. E., Xu, J., Chai, X., Vemuri, P., et al. (2018) Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau-and amyloid-positron emission tomography, Alzheimer\u2019s Dement., 14, 989-997, \nhttps:\/\/doi.org\/10.1016\/j.jalz.2018.02.013.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR67","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"T. K. Karikari","year":"2020","unstructured":"Karikari, T. K., Pascoal, T. A., Ashton, N. J., Janelidze, S., Benedet, A. L., et al. (2020) Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts, Lancet Neurol., 19, 422-433, \nhttps:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5.","journal-title":"Lancet Neurol."},{"key":"2345_CR68","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S. Palmqvist","year":"2020","unstructured":"Palmqvist, S., Janelidze, S., Quiroz, Y. T., Zetterberg, H., Lopera, F., et al. (2020) Discriminative accuracy of plasma phospho-tau217 for Alzheimer\u2019s disease vs other neurodegenerative disorders, JAMA, 324, 772-781, \nhttps:\/\/doi.org\/10.1001\/jama.2020.12134.","journal-title":"JAMA"},{"key":"2345_CR69","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","volume":"97","author":"C. Sato","year":"2018","unstructured":"Sato, C., Barth\u00e9lemy, N. R., Mawuenyega, K. G., Patterson, B. W., Gordon, B. A., et al. (2018) Tau kinetics in neurons and the human central nervous system, Neuron, 97, 1284-1298, \nhttps:\/\/doi.org\/10.1016\/j.neuron.2018.02.015.","journal-title":"Neuron"},{"key":"2345_CR70","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.resuscitation.2012.07.027","volume":"84","author":"J. Randall","year":"2013","unstructured":"Randall, J., M\u00f6rtberg, E., Provuncher, G. K., Fournier, D. R., Duffy, D. C., et al. (2013) Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study, Resuscitation, 84, 351-356, \nhttps:\/\/doi.org\/10.1016\/j.resuscitation.2012.07.027.","journal-title":"Resuscitation"},{"key":"2345_CR71","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3233\/JAD-2011-110731","volume":"27","author":"M. Shi","year":"2011","unstructured":"Shi, M., Sui, Y. T., Peskind, E. R., Li, G., Hwang, H., et al. (2011) Salivary tau species are potential biomarkers of Alzheimer\u2019s disease, J. Alzheimer\u2019s Dis., 27, 299-305, \nhttps:\/\/doi.org\/10.3233\/JAD-2011-110731.","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"2345_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/s1041610298005110","volume":"10","author":"P. Davidsson","year":"1998","unstructured":"Davidsson, P., and Blennow, K. (1998) Neurochemical dissection of synaptic pathology in Alzheimer\u2019s disease, Int. Psychogeriatr., 10, 11-23, \nhttps:\/\/doi.org\/10.1017\/s1041610298005110.","journal-title":"Int. Psychogeriatr."},{"key":"2345_CR73","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","volume":"11","author":"H. Kvartsberg","year":"2015","unstructured":"Kvartsberg, H., Duits, F. H., Ingelsson, M., Andreasen, N., \u00d6hrfelt, A., et al. (2015) Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer\u2019s disease, Alzheimer\u2019s Dement., 11, 1180-1190, \nhttps:\/\/doi.org\/10.1016\/j.jalz.2014.10.009.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-015-0161-y","volume":"7","author":"K. Hellwig","year":"2015","unstructured":"Hellwig, K., Kvartsberg, H., Portelius, E., Andreasson, U., Oberstein, T. J., et al. (2015) Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer\u2019s disease, Alzheimer\u2019s Res. Ther., 7, 1-8, \nhttps:\/\/doi.org\/10.1186\/s13195-015-0161-y.","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"2345_CR75","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1093\/brain\/awv267","volume":"138","author":"E. Portelius","year":"2015","unstructured":"Portelius, E., Zetterberg, H., Skillb\u00e4ck, T., T\u00f6rnqvist, U., Andreasson, U., et al. (2015) Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer\u2019s disease, Brain, 138, 3373-3385, \nhttps:\/\/doi.org\/10.1093\/brain\/awv267.","journal-title":"Brain"},{"key":"2345_CR76","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","volume":"86","author":"H. Wellington","year":"2016","unstructured":"Wellington, H., Paterson, R. W., Portelius, E., T\u00f6rnqvist, U., Magdalinou, N., et al. (2016) Increased CSF neurogranin concentration is specific to Alzheimer\u2019s disease, Neurology, 86, 829-835, \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000002423.","journal-title":"Neurology"},{"key":"2345_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-016-0208-8","volume":"8","author":"A. \u00d6hrfelt","year":"2016","unstructured":"\u00d6hrfelt, A., Brinkmalm, A., Dumurgier, J., Brinkmalm, G., Hansson, O., et al. (2016) The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer\u2019s disease, Alzheimer\u2019s Res. Ther., 8, 1-10, \nhttps:\/\/doi.org\/10.1186\/s13195-016-0208-8.","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"2345_CR78","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1096\/fj.201600816R","volume":"30","author":"E. J. Goetzl","year":"2016","unstructured":"Goetzl, E. J., Kapogiannis, D., Schwartz, J. B., Lobach, I. V., Goetzl, L., et al. (2016) Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer\u2019s disease, FASEB J., 30, 4141-4148, \nhttps:\/\/doi.org\/10.1096\/fj.201600816R.","journal-title":"FASEB J."},{"key":"2345_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-9-53","volume":"9","author":"A. Brinkmalm","year":"2014","unstructured":"Brinkmalm, A., Brinkmalm, G., Honer, W. G., Fr\u00f6lich, L., Hausner, L., et al. (2014) SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer\u2019s disease, Mol. Neurodegener., 9, 1-13, \nhttps:\/\/doi.org\/10.1186\/1750-1326-9-53.","journal-title":"Mol. Neurodegener."},{"key":"2345_CR80","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.031781","volume":"11","author":"T. Lashley","year":"2018","unstructured":"Lashley, T., Schott, J. M., Weston, P., Murray, C. E., Wellington, H., et al. (2018) Molecular biomarkers of Alzheimer\u2019s disease: progress and prospect, Dis. Model. Mech., 11, dmm031781, \nhttps:\/\/doi.org\/10.1242\/dmm.031781.","journal-title":"Dis. Model. Mech."},{"key":"2345_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135458","volume":"10","author":"M. Wennstr\u00f6m","year":"2015","unstructured":"Wennstr\u00f6m, M., Surova, Y., Hall, S., Nilsson, C., Minthon, L., et al. (2015) The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer\u2019s but not Parkinson\u2019s disease or dementia with Lewy bodies, PLoS One, 10, e0135458, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0135458.","journal-title":"PLoS One"},{"key":"2345_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/acn3.266","volume":"3","author":"S. Janelidze","year":"2016","unstructured":"Janelidze, S., Hertze, J., Zetterberg, H., Landqvist Wald\u00f6, M., Santillo, A., et al. (2016) Cerebrospinal fluid neurogranin and YKL\u201040 as biomarkers of Alzheimer\u2019s disease, Ann. Clin. Transl. Neurol., 3, 12-20, \nhttps:\/\/doi.org\/10.1002\/acn3.266.","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"2345_CR83","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E. Morenas-Rodr\u00edguez","year":"2022","unstructured":"Morenas-Rodr\u00edguez, E., Li, Y., Nuscher, B., Franzmeier, N., Xiong, C., et al. (2022) Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study, Lancet Neurol., 21, 329-341, \nhttps:\/\/doi.org\/10.1016\/S1474-4422(22)00027-8.","journal-title":"Lancet Neurol."},{"key":"2345_CR84","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12017-011-8147-9","volume":"13","author":"N. Mattsson","year":"2011","unstructured":"Mattsson, N., Tabatabaei, S., Johansson, P., Hansson, O., Andreasson, U., et al. (2011) Cerebrospinal fluid microglial markers in Alzheimer\u2019s disease: elevated chitotriosidase activity but lack of diagnostic utility, Neuromolecular Med., 13, 151-159, \nhttps:\/\/doi.org\/10.1007\/s12017-011-8147-9.","journal-title":"Neuromolecular Med."},{"key":"2345_CR85","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ana.22448","volume":"70","author":"R. Tarawneh","year":"2011","unstructured":"Tarawneh, R., D\u2019Angelo, G., Macy, E., Xiong, C., Carter, D., et al. (2011) Visinin\u2010like protein\u20101: diagnostic and prognostic biomarker in Alzheimer\u2019s disease, Ann. Neurol., 70, 274-285, \nhttps:\/\/doi.org\/10.1002\/ana.22448.","journal-title":"Ann. Neurol."},{"key":"2345_CR86","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M. Khalil","year":"2018","unstructured":"Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., et al. (2018) Neurofilaments as biomarkers in neurological disorders, Nat. Rev. Neurol., 14, 577-589, \nhttps:\/\/doi.org\/10.1038\/s41582-018-0058-z.","journal-title":"Nat. Rev. Neurol."},{"key":"2345_CR87","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","volume":"3","author":"M. Gissl\u00e9n","year":"2016","unstructured":"Gissl\u00e9n, M., Price, R. W., Andreasson, U., Norgren, N., Nilsson, S., et al. (2016) Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study, EBioMedicine, 3, 135-140, \nhttps:\/\/doi.org\/10.1016\/j.ebiom.2015.11.036.","journal-title":"EBioMedicine"},{"key":"2345_CR88","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N. Mattsson","year":"2017","unstructured":"Mattsson, N., Andreasson, U., Zetterberg, H., Blennow, K., and Alzheimer\u2019s Disease Neuroimaging Initiative (2017) Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer\u2019s disease, JAMA Neurol., 74, 557-566, \nhttps:\/\/doi.org\/10.1001\/jamaneurol.2016.6117.","journal-title":"JAMA Neurol."},{"key":"2345_CR89","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/mp.2014.117","volume":"20","author":"B. S. Fernandes","year":"2015","unstructured":"Fernandes, B. S., Steiner, J., Berk, M., Molendijk, M. L., Gonzalez-Pinto, A., et al. (2015) Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications, Mol. Psychiatry, 20, 1108-1119, \nhttps:\/\/doi.org\/10.1038\/mp.2014.117.","journal-title":"Mol. Psychiatry"},{"key":"2345_CR90","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/mp.2016.62","volume":"22","author":"X. Y. Qin","year":"2017","unstructured":"Qin, X. Y., Cao, C., Cawley, N. X., Liu, T. T., Yuan, J., et al. (2017) Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer\u2019s disease: a meta-analysis study (N = 7277), Mol. Psychiatry, 22, 312-320, \nhttps:\/\/doi.org\/10.1038\/mp.2016.62.","journal-title":"Mol. Psychiatry"},{"key":"2345_CR91","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/rej.2020.2307","volume":"23","author":"M. Balietti","year":"2020","unstructured":"Balietti, M., Giuli, C., Casoli, T., Fabbietti, P., and Conti, F. (2020) Is blood brain-derived neurotrophic factor a useful biomarker to monitor mild cognitive impairment patients? Rejuvenation Res., 23, 411-419, \nhttps:\/\/doi.org\/10.1089\/rej.2020.2307.","journal-title":"Rejuvenation Res."},{"key":"2345_CR92","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/ijms23031217","volume":"23","author":"A. Morozova","year":"2022","unstructured":"Morozova, A., Zorkina, Y., Abramova, O., Pavlova, O., Pavlov, K., et al. (2022) Neurobiological highlights of cognitive impairment in psychiatric disorders, Int. J. Mol. Sci., 23, 1217, \nhttps:\/\/doi.org\/10.3390\/ijms23031217.","journal-title":"Int. J. Mol. Sci."},{"key":"2345_CR93","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","volume":"90","author":"X. N. Shen","year":"2019","unstructured":"Shen, X. N., Niu, L. D., Wang, Y. J., Cao, X. P., Liu, Q., et al. (2019) Inflammatory markers in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies, J. Neurol. Neurosurg. Psychiatry, 90, 590-598, \nhttps:\/\/doi.org\/10.1136\/jnnp-2018-319148.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2345_CR94","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuroscience.2012.06.029","volume":"220","author":"S. C. F. Marques","year":"2012","unstructured":"Marques, S. C. F., Lemos, R., Ferreiro, E., Martins, M., De Mendonca, A., et al. (2012) Epigenetic regulation of BACE1 in Alzheimer\u2019s disease patients and in transgenic mice, Neuroscience, 220, 256-266, \nhttps:\/\/doi.org\/10.1016\/j.neuroscience.2012.06.029.","journal-title":"Neuroscience"},{"key":"2345_CR95","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/archpsyc.64.6.718","volume":"64","author":"Z. Zhong","year":"2007","unstructured":"Zhong, Z., Ewers, M., Teipel, S., B\u00fcrger, K., Wallin, A., et al. (2007) Levels of \u03b2-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment, Arch. Gen. Psychiatry, 64, 718-726, \nhttps:\/\/doi.org\/10.1001\/archpsyc.64.6.718.","journal-title":"Arch. Gen. Psychiatry"},{"key":"2345_CR96","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","volume":"61","author":"C. Bellenguez","year":"2020","unstructured":"Bellenguez, C., Grenier-Boley, B., and Lambert, J. C. (2020) Genetics of Alzheimer\u2019s disease: where we are, and where we are going, Curr. Opin. Neurobiol., 61, 40-48, \nhttps:\/\/doi.org\/10.1016\/j.conb.2019.11.024.","journal-title":"Curr. Opin. Neurobiol."},{"key":"2345_CR97","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"B. W. Kunkle","year":"2019","unstructured":"Kunkle, B. W., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., et al. (2019) Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing, Nat. Genet., 51, 414-430, \nhttps:\/\/doi.org\/10.1038\/s41588-019-0358-2.","journal-title":"Nat. Genet."},{"key":"2345_CR98","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"C. M. Karch","year":"2015","unstructured":"Karch, C. M., and Goate, A. M. (2015) Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis, Biol. Psychiatry, 77, 43-51, \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2014.05.006.","journal-title":"Biol. Psychiatry"},{"key":"2345_CR99","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J. Kim","year":"2009","unstructured":"Kim, J., Basak, J. M., and Holtzman, D. M. (2009) The role of apolipoprotein E in Alzheimer\u2019s disease, Neuron, 63, 287-303, \nhttps:\/\/doi.org\/10.1016\/j.neuron.2009.06.026.","journal-title":"Neuron"},{"key":"2345_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101066","volume":"60","author":"S. H. Rehiman","year":"2020","unstructured":"Rehiman, S. H., Lim, S. M., Neoh, C. F., Majeed, A. B. A., Chin, A. V., et al. (2020) Proteomics as a reliable approach for discovery of blood-based Alzheimer\u2019s disease biomarkers: a systematic review and meta-analysis, Ageing Res. Rev., 60, 101066, \nhttps:\/\/doi.org\/10.1016\/j.arr.2020.101066.","journal-title":"Ageing Res. Rev."},{"key":"2345_CR101","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.neuroimage.2014.08.041","volume":"102","author":"A. Nazeri","year":"2014","unstructured":"Nazeri, A., Ganjgahi, H., Roostaei, T., Nichols, T., Zarei, M., et al. (2014) Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer\u2019s disease, Neuroimage, 102, 657-665, \nhttps:\/\/doi.org\/10.1016\/j.neuroimage.2014.08.041.","journal-title":"Neuroimage"},{"key":"2345_CR102","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/WAD.0b013e31827b60d2","volume":"27","author":"L. H. Guo","year":"2013","unstructured":"Guo, L. H., Alexopoulos, P., Wagenpfeil, S., Kurz, A., Perneczky, R., et al. (2013) Plasma proteomics for the identification of Alzheimer\u2019s disease, Alzheimer Dis. Assoc. Disord., 27, 337-342, \nhttps:\/\/doi.org\/10.1097\/WAD.0b013e31827b60d2.","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"2345_CR103","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/ijms20061394","volume":"20","author":"O. Mancera-P\u00e1ez","year":"2019","unstructured":"Mancera-P\u00e1ez, O., Estrada-Orozco, K., Mahecha, M. F., Cruz, F., Bonilla-Vargas, K., et al. (2019) Differential methylation in APOE (Chr19; Exon four; from 44,909,188 to 44,909,373\/hg38) and increased apolipoprotein E plasma levels in subjects with mild cognitive impairment, Int. J. Mol. Sci., 20, 1394, \nhttps:\/\/doi.org\/10.3390\/ijms20061394.","journal-title":"Int. J. Mol. Sci."},{"key":"2345_CR104","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L","volume":"50","author":"M. Calero","year":"2000","unstructured":"Calero, M., Rostagno, A., Matsubara, E., Zlokovic, B., Frangione, B., et al. (2000) Apolipoprotein J (clusterin) and Alzheimer\u2019s disease, Microsc. Res. Tech., 50, 305-315, \nhttps:\/\/doi.org\/10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L.","journal-title":"Microsc. Res. Tech."},{"key":"2345_CR105","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"R. B. DeMattos","year":"2002","unstructured":"DeMattos, R. B., O\u2019dell, M. A., Parsadanian, M., Taylor, J. W., Harmony, J. A., et al. (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease, Proc. Natl Acad. Sci. USA, 99, 10843-10848, \nhttps:\/\/doi.org\/10.1073\/pnas.162228299.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2345_CR106","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","volume":"67","author":"M. Thambisetty","year":"2010","unstructured":"Thambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., et al. (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer\u2019s disease, Arch. Gen. Psychiatry, 67, 739-748, \nhttps:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.78.","journal-title":"Arch. Gen. Psychiatry"},{"key":"2345_CR107","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","volume":"45","author":"J. T. Yu","year":"2012","unstructured":"Yu, J. T., and Tan, L. (2012) The role of clusterin in Alzheimer\u2019s disease: pathways, pathogenesis, and therapy, Mol. Neurobiol., 45, 314-326, \nhttps:\/\/doi.org\/10.1007\/s12035-012-8237-1.","journal-title":"Mol. Neurobiol."},{"key":"2345_CR108","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","volume":"15","author":"A. R. Morgan","year":"2019","unstructured":"Morgan, A. R., Touchard, S., Leckey, C., O\u2019Hagan, C., Nevado-Holgado, A. J., et al. (2019) Inflammatory biomarkers in Alzheimer\u2019s disease plasma, Alzheimer\u2019s Dement., 15, 776-787, \nhttps:\/\/doi.org\/10.1016\/j.jalz.2019.03.007.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR109","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/rcm.3357","volume":"22","author":"I. Y. Toropygin","year":"2008","unstructured":"Toropygin, I. Y., Kugaevskaya, E. V., Mirgorodskaya, O. A., Elisseeva, Y. E., Kozmin, Y. P., et al. (2008) The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer\u2019s A\u03b2-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry, Rapid Commun. Mass Spectrom., 22, 231-239, \nhttps:\/\/doi.org\/10.1002\/rcm.3357.","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"2345_CR110","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jns.2010.09.030","volume":"300","author":"H. Akatsu","year":"2011","unstructured":"Akatsu, H., Ogawa, N., Kanesaka, T., Hori, A., Yamamoto, T., et al. (2011) Higher activity of peripheral blood angiotensin-converting enzyme is associated with later-onset of Alzheimer\u2019s disease, J. Neurol. Sci., 300, 67-73, \nhttps:\/\/doi.org\/10.1016\/j.jns.2010.09.030.","journal-title":"J. Neurol. Sci."},{"key":"2345_CR111","first-page":"163","volume":"1","author":"S. Miners","year":"2009","unstructured":"Miners, S., Ashby, E., Baig, S., Harrison, R., Tayler, H., et al. (2009) Angiotensin-converting enzyme levels and activity in Alzheimer\u2019s disease: differences in brain and CSF ACE and association with ACE1 genotypes, Am. J. Transl. Res., 1, 163-177.","journal-title":"Am. J. Transl. Res."},{"key":"2345_CR112","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"J. W. Kinney","year":"2018","unstructured":"Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., et al. (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease, Alzheimer\u2019s Dement., 4, 575-590, \nhttps:\/\/doi.org\/10.1016\/j.trci.2018.06.014.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR113","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3233\/JAD-130380","volume":"38","author":"S. J. Kiddle","year":"2014","unstructured":"Kiddle, S. J., Sattlecker, M., Proitsi, P., Simmons, A., Westman, E., et al. (2014) Candidate blood proteome markers of Alzheimer\u2019s disease onset and progression: a systematic review and replication study, J. Alzheimer\u2019s Dis., 38, 515-531, \nhttps:\/\/doi.org\/10.3233\/JAD-130380.","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"2345_CR114","doi-asserted-by":"publisher","first-page":"D394","DOI":"10.1093\/nar\/gkaa1106","volume":"49","author":"H. Mi","year":"2021","unstructured":"Mi, H., Ebert, D., Muruganujan, A., Mills, C., Albou, L. P., et al. (2021) PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API, Nucleic Acids Res., 49, D394-D403, \nhttps:\/\/doi.org\/10.1093\/nar\/gkaa1106.","journal-title":"Nucleic Acids Res."},{"key":"2345_CR115","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S. Ray","year":"2007","unstructured":"Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., et al. (2007) Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins, Nat. Med., 13, 1359-1362, \nhttps:\/\/doi.org\/10.1038\/nm1653.","journal-title":"Nat. Med."},{"key":"2345_CR116","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"J. D. Doecke","year":"2012","unstructured":"Doecke, J. D., Laws, S. M., Faux, N. G., Wilson, W., Burnham, S. C., et al. (2012) Blood-based protein biomarkers for diagnosis of Alzheimer\u2019s disease, Arch. Neurol., 69, 1318-1325, \nhttps:\/\/doi.org\/10.1001\/archneurol.2012.1282.","journal-title":"Arch. Neurol."},{"key":"2345_CR117","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1001\/archneurol.2010.215","volume":"67","author":"S. E. O\u2019Bryant","year":"2010","unstructured":"O\u2019Bryant, S. E., Xiao, G., Barber, R., Reisch, J., Doody, R., et al. (2010) A serum protein-based algorithm for the detection of Alzheimer disease, Arch. Neurol., 67, 1077-1081, \nhttps:\/\/doi.org\/10.1001\/archneurol.2010.215.","journal-title":"Arch. Neurol."},{"key":"2345_CR118","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.dadm.2016.06.004","volume":"3","author":"S. E. O\u2019Bryant","year":"2016","unstructured":"O\u2019Bryant, S. E., Edwards, M., Johnson, L., Hall, J., Villarreal, A. E., et al. (2016) A blood screening test for Alzheimer\u2019s disease, Alzheimer\u2019s Dement., 3, 83-90, \nhttps:\/\/doi.org\/10.1016\/j.dadm.2016.06.004.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR119","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jalz.2014.05.1749","volume":"10","author":"A. Hye","year":"2014","unstructured":"Hye, A., Riddoch-Contreras, J., Baird, A. L., Ashton, N. J., Bazenet, C., et al. (2014) Plasma proteins predict conversion to dementia from prodromal disease, Alzheimer\u2019s Dement., 10, 799-807, \nhttps:\/\/doi.org\/10.1016\/j.jalz.2014.05.1749.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR120","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1007\/s12035-017-0609-0","volume":"55","author":"S. Yu","year":"2018","unstructured":"Yu, S., Liu, Y. P., Liu, H. L., Li, J., Xiang, Y., et al. (2018) Serum protein-based profiles as novel biomarkers for the diagnosis of Alzheimer\u2019s disease, Mol. Neurobiol., 55, 3999-4008, \nhttps:\/\/doi.org\/10.1007\/s12035-017-0609-0.","journal-title":"Mol. Neurobiol."},{"key":"2345_CR121","doi-asserted-by":"publisher","first-page":"712545","DOI":"10.3389\/fnagi.2021.712545","volume":"13","author":"L. Shi","year":"2021","unstructured":"Shi, L., Buckley, N.J., Bos, I., Engelborghs, S., Sleegers, K., et al. (2021) Plasma proteomic biomarkers relating to Alzheimer\u2019s disease: a meta-analysis based on our own studies, Front. Aging Neurosci., 13, 712545, \nhttps:\/\/doi.org\/10.3389\/fnagi.2021.712545.","journal-title":"Front. Aging Neurosci."},{"key":"2345_CR122","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00702-012-0781-3","volume":"119","author":"A. W. Henkel","year":"2012","unstructured":"Henkel, A. W., Muller, K., Lewczuk, P., Muller, T., Marcus, K., et al. (2012) Multidimensional plasma protein separation technique for identification of potential Alzheimer\u2019s disease plasma biomarkers: A pilot study, J. Neural. Transm., 119, 779-788, \nhttps:\/\/doi.org\/10.1007\/s00702-012-0781-3.","journal-title":"J. Neural. Transm."},{"key":"2345_CR123","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","volume":"1","author":"K. A. Walke","year":"2021","unstructured":"Walke, K. A., Chen, J., Zhang, J., Fornage, M., Yang, Y., et al. (2021) Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk, Nat. Aging, 1, 473-489, \nhttps:\/\/doi.org\/10.1038\/s43587-021-00064-0.","journal-title":"Nat. Aging"},{"key":"2345_CR124","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","volume":"7","author":"C. D. Whelan","year":"2019","unstructured":"Whelan, C. D., Mattsson, N., Nagle, M. W., Vijayaraghavan, S., Hyde, C., et al. (2019) Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease, Acta Neuropathol. Commun., 7, 169, \nhttps:\/\/doi.org\/10.1186\/s40478-019-0795-2.","journal-title":"Acta Neuropathol. Commun."},{"key":"2345_CR125","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/alz.12369","volume":"18","author":"Y. Jiang","year":"2021","unstructured":"Jiang, Y., Zhou, X., Ip, F. C., Chan, P., Chen, Y., et al. (2021) Large-scale proteomic profiling identifies a high-performance biomarker panel for Alzheimer\u2019s disease screening and staging, Alzheimer\u2019s Dement., 18, 88-102, \nhttps:\/\/doi.org\/10.1002\/alz.12369.","journal-title":"Alzheimer\u2019s Dement."},{"key":"2345_CR126","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3233\/JAD-170426","volume":"60","author":"L. Dayon","year":"2017","unstructured":"Dayon, L., Wojcik, J., Galindo, N., Corthesy, J., Cominetti, O., et al. (2017) Plasma proteomic profiles of cerebrospinal fluid-defined Alzheimer\u2019s disease pathology in older adults, J. Alzheimer\u2019s Dis., 60, 1641-1652, \nhttps:\/\/doi.org\/10.3233\/JAD-170426.","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"2345_CR127","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12014-019-9237-1","volume":"16","author":"K.K. Dey","year":"2019","unstructured":"Dey, K.K., Wang, H., Niu, M., Bai, B., Wang, X., et al. (2019) Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer\u2019s disease, Clin. Proteomics, 16, 16, \nhttps:\/\/doi.org\/10.1186\/s12014-019-9237-1.","journal-title":"Clin. Proteomics"},{"key":"2345_CR128","doi-asserted-by":"publisher","first-page":"101690","DOI":"10.1016\/j.pneurobio.2019.101690","volume":"183","author":"J. C. Park","year":"2019","unstructured":"Park, J. C., Han, S.H., Lee, H., Jeong, H., Byun, M. S., et al. (2019) Prognostic plasma protein panel for A\u03b2 deposition in the brain in Alzheimer\u2019s disease, Prog. Neurobiol., 183, 101690, \nhttps:\/\/doi.org\/10.1016\/j.pneurobio.2019.101690.","journal-title":"Prog. Neurobiol."},{"key":"2345_CR129","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau7220","volume":"5","author":"N. J. Ashton","year":"2019","unstructured":"Ashton, N. J., Nevado-Holgado, A. J., Barber, I. S., Lynham, S., Gupta, V., et al. (2019) A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer\u2019s disease, Sci. Adv., 5, eaau7220, \nhttps:\/\/doi.org\/10.1126\/sciadv.aau7220.","journal-title":"Sci. Adv."},{"key":"2345_CR130","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JAD-200110","volume":"76","author":"M. Chen","year":"2020","unstructured":"Chen, M., and Xia, W. (2020) Proteomic profiling of plasma and brain tissue from Alzheimer\u2019s disease patients reveals candidate network of plasma biomarkers, J. Alzheimer\u2019s Dis., 76, 349-368, \nhttps:\/\/doi.org\/10.3233\/JAD-200110.","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"2345_CR131","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/proteomes9010013","volume":"9","author":"A. P. Jain","year":"2021","unstructured":"Jain, A. P., and Sathe, G. (2021) Proteomics landscape of Alzheimer\u2019s disease, Proteomes, 9, 13, \nhttps:\/\/doi.org\/10.3390\/proteomes9010013.","journal-title":"Proteomes"},{"key":"2345_CR132","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/01616412.2017.1281195","volume":"39","author":"Y. Kitamura","year":"2017","unstructured":"Kitamura, Y., Usami, R., Ichichara, S., Kida, H., Satoh, M., et al. (2017) Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer\u2019s disease, Neurol. Res., 39, 231-238, \nhttps:\/\/doi.org\/10.1080\/01616412.2017.1281195.","journal-title":"Neurol. Res."},{"key":"2345_CR133","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neulet.2018.04.015","volume":"676","author":"A. Kumar","year":"2018","unstructured":"Kumar, A., Singh, S., Verma, A., and Mishra, V. N. (2018) Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer\u2019s disease, Neurosci. Lett., 676, 71-77, \nhttps:\/\/doi.org\/10.1016\/j.neulet.2018.04.015.","journal-title":"Neurosci. Lett."},{"key":"2345_CR134","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3233\/JAD-141149","volume":"43","author":"X. Zhao","year":"2015","unstructured":"Zhao, X., Lejnine, S., Spond, J., Zhang, C., Ramaraj, T. C., et al. (2015) A candidate plasma protein classifier to identify Alzheimer\u2019s disease, J. Alzheimer\u2019s Dis., 43, 549-563, \nhttps:\/\/doi.org\/10.3233\/JAD-141149.","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"2345_CR135","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20199356","volume":"16","author":"J. M. Bader","year":"2020","unstructured":"Bader, J. M., Geyer, P. E., M\u00fcller, J. B., Strauss, M. T., Koch, M., et al. (2020) Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease, Mol. Syst. Biol., 16, e9356, \nhttps:\/\/doi.org\/10.15252\/msb.20199356.","journal-title":"Mol. Syst. Biol."},{"key":"2345_CR136","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1039\/c9an01893j","volume":"145","author":"C. Gaither","year":"2020","unstructured":"Gaither, C., Popp, R., Mohammed, Y., and Bochers, C. H. (2020) Determination of the concentration range for 267 proteins from 21 lots of commercial human plasma using highly multiplexed multiple reaction monitoring mass spectrometry, Analyst, 145, 3634-3644, \nhttps:\/\/doi.org\/10.1039\/c9an01893j.","journal-title":"Analyst"},{"key":"2345_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101904","volume":"198","author":"S. Ayton","year":"2021","unstructured":"Ayton, S., Janelidze, S., Roberts, B., Palmqvist, S., Kalinowski, P., et al. (2021) Acute phase markers in CSF reveal inflammatory changes in Alzheimer\u2019s disease that intersect with pathology, APOE \u03b54, sex and age, Prog. Neurobiol., 198, 101904, \nhttps:\/\/doi.org\/10.1016\/j.pneurobio.2020.101904.","journal-title":"Prog. Neurobiol."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297922080089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297922080089","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297922080089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:25:59Z","timestamp":1773620759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297922080089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":137,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1134\/s0006297922080089","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest in financial or any other sphere. This article does not include the experiments involving humans or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}